课题基金 / 基金详情

Gene Therapy of Combined Nitric Oxide Synthases and Related Enzymes to Achieve Complete Regression of Advanced Atherosclerosis-Combined Regulation of Substrate of the Enzymes, Co-factors, Transcriptional Factors and Intracellular Enzymes-

Gene Therapy of Combined Nitric Oxide Synthases and Related Enzymes to Achieve Complete Regression of Advanced Atherosclerosis-Combined Regulation of Substrate of the Enzymes, Co-factors, Transcriptional Factors and Intracellular Enzymes-
一氧化氮合成酶及相关酶联合基因治疗,实现晚期动脉粥样硬化的彻底消退-酶底物、辅因子、转录因子和细胞内酶的联合调控-
批准号:
13670704
负责人:
HAYASHI Toshio
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003

项目摘要

项目成果

HAYASHI Toshio的其他基金

相似基金

相关文献

中文摘要
翻译
背景)我们先前发现,在球囊损伤+高胆固醇饮食诱导的兔动脉粥样硬化中,通过体内基因转移eNOS可以部分消退。(JSPS科学研究补助金(B)项目编号09470166)。目的)探讨eNOS、iNOS及相关酶联合基因转移对动脉粥样硬化(AS)血管充分消退的可能性方法)1)探讨eNOS、iNOS及eNOS+iNOS联合基因转移对AS血管充分消退的可能性。2)成功制备了ERα(雌激素受体α)腺病毒载体。3)制备自发性糖尿病大鼠和老年大鼠的动脉。本实验观察了eNOS、iNOS或eNOS+iNOS基因转染对血管功能的影响。4)阐明了内皮细胞中的酰化和小窝的功能及其与eNOS的关系。 ...更多信息 5)阐明了iNOS在血管功能中的促进或抑制作用。6)探讨eNOS、iNOS或ERα基因联合转染对动脉粥样硬化的治疗作用。结果1)eNOS基因转染可使动脉粥样硬化部分消退,而iNOS或eNOS+iNOS基因转染不能使动脉粥样硬化部分消退。2)制备ERα腺病毒载体,观察其基因转染后NO释放的增加。3)制备自发性糖尿病大鼠动脉和老年大鼠动脉。eNOS基因转染可改善血管功能。4)eNOS的酰化是内皮细胞存活的关键。小窝的形态变化与eNOS活性的变化有关。5)iNOS的siRNA改善血管功能。6)eNOS + ERα联合基因转染可使晚期动脉粥样硬化部分但充分消退,而iNOS不能。结论)eNOS + ERα联合基因转染可使晚期动脉粥样硬化部分但充分消退,而eNOS + iNOS或iNOS + ERα联合基因转染则不能。联合基因转移可能成为实现动脉粥样硬化消退的一种工具。少
英文摘要
Background)We previously found the partial regression by in vivo gene transfer of eNOS in balloon injury + high-cholesterol diet induced atherosclerosis in rabbit. (JSPS Grant-in-Aid for Scientific Research (B) project number 09470166). However, the regression was not sufficient and the mechanism was not well known.Objectives)We investigated the possibility of the sufficient regression by combined gene transfer of eNOS, iNOS and related enzymes in atherosclerotic arteries.Methods)1) We investigated the possibility of the sufficient regression by combined gene transfer of eNOS, iNOS or eNOS+iNOS in advanced atherosclerotic arteries. 2)We produced adenovirus vector of ERα(estrogen receptor α). 3)We prepared the arteries from spontaneously developed diabetic rats and those from senile rats. We investigated the effect of gene transfer of eNOS, iNOS or eNOS+iNOS on their vascular function. 4)We elucidated the function of acylation and caveolae with the relation to eNOS in endothelial cells. … More 5)We elucidated the effect of promotion or inhibition of iNOS in vascular function. 6)We investigated the possibility of the sufficient regression by combined gene transfer of eNOS, iNOS or ERα in advanced atherosclerotic arteries.Results)1)In vivo gene transfer of eNOS, but not iNOS or eNOS+iNOS partially regressed the advanced atherosclerotic arteries. 2)We produced adenovirus vector of ERα and observed the increase of NO release its gene transfer on. 3)We prepared the arteries from spontaneously developed diabetic rats and those from senile rats. We eNOS gene transfer improved their vascular function. 4)Acylation of eNOS is critica for survival of endothelial cell. The morphology of caveolae changes with the relation of eNOS activity. 5)SiRNA of iNOS improved vascular function. 6)We achieved the partial but sufficient regression by combined gene transfer of eNOS plus ERα,but not iNOS in advanced atherosclerotic arteries.Conclusion)Combined gene transfer of eNOS plus ERα,but not eNOS plus iNOS or iNOS plus ERα made possible partial but sufficient regression in advanced atherosclerotic arteries. Combined gene transfer may become one tool to achieve regression of atherosclerosis. Less
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
Hayashi T, Iguchi A 他3名: "Gene transfer of endothelial NO synthase, (eNOS),but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits"Cardiovascular Research. 61. 339-351 (2004)
Hayashi T、Iguchi A 和其他 3 人:“内皮 NO 合酶 (eNOS) 的基因转移,但不是 eNOS 加诱导型 NOS,使兔子的动脉粥样硬化消退”《心血管研究》61. 339-351 (2004)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Kano, T.Hayashi, et al.: "Estriol retards and stabilizes atherosclerosis through an NO-mediated system"Life Sciences. 71. 31-42 (2002)
H.Kano、T.Hayashi 等人:“雌三醇通过一氧化氮介导的系统延缓和稳定动脉粥样硬化”生命科学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Hayashi, H Kano.et al.: "The long-term effect of estriol on endothelial function and bone mineral density in octogenarian women.."Journal of American Geriatric Society. 50. 777-778 (2002)
T.Hayashi、H Kano 等人:“雌三醇对八旬女性内皮功能和骨矿物质密度的长期影响。”美国老年医学会杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Arockia Rani P J, Hayashi T他3名: "Concomitant production of nitric oxide and superoxide in human"Biocim Biophys Res Commun. 310. 367-370 (2003)
Arockia Rani P J、Hayashi T 和其他 3 人:“人体中一氧化氮和超氧化物的同时产生”Biocim Biophys Res Commun. 310. 367-370 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 27 条
    The regression of atherosclerosis through the regulation of cellular senescence: the possible new therapy for Japanese lifestyle related diseases
    • 批准号:
      24590881
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      HAYASHI Toshio
    • 依托单位:
    Investigation of the regression of advanced atherosclerosis through the regulation of cellular senescence-custom-made therapy to Japanese elderly-
    • 批准号:
      21590762
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      HAYASHI Toshio
    • 依托单位:
    Geriatric and gerontological approach for asian elderly to prevent their atherosclerotic disease and get successful aging.
    • 批准号:
      20406004
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.73万
    • 财政年份:
      2008
    • 负责人:
      HAYASHI Toshio
    • 依托单位:
    Regression of Atherosclerosis by the regulation of nitric oxide and superoxide on vascular endocrinology and vascular aging
    • 批准号:
      19591043
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2007
    • 负责人:
      HAYASHI Toshio
    • 依托单位:
    国内基金
    海外基金
    卡路里限制的T细胞糖脂代谢重塑机制及网络调控
    • 批准号:
      91957111
    • 项目类别:
      重大研究计划
    • 资助金额:
      80.0万元
    • 批准年份:
      2019
    • 负责人:
      李佩盈
    • 依托单位:
    高尿酸血症促进动脉粥样硬化机制探讨
    • 批准号:
      81170251
    • 项目类别:
      面上项目
    • 资助金额:
      14.0万元
    • 批准年份:
      2011
    • 负责人:
      刘梅林
    • 依托单位:
    磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
    • 批准号:
      81070247
    • 项目类别:
      面上项目
    • 资助金额:
      33.0万元
    • 批准年份:
      2010
    • 负责人:
      秦树存
    • 依托单位:
    大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
    • 批准号:
      81000086
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2010
    • 负责人:
      江立生
    • 依托单位: